Microbio Co., Ltd. Statistics
Microbio Co., Ltd. (4128) Stock Statistics & Valuation Metrics
Total Valuation
Microbio Co., Ltd. has a market cap or net worth of TWD 7.71B. The enterprise value is TWD 8.50B.
- Market Cap
- TWD 7.71B
- Enterprise Value
- TWD 8.50B
Share Statistics
Microbio Co., Ltd. has 588,170,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 588,170,600
- Owned by Insiders
- ―
- Owned by Institutions
- 2.45%
Financial Efficiency
Microbio Co., Ltd.’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -3.48%.
- Return on Equity (ROE)
- -0.09
- Return on Assets (ROA)
- -0.06
- Return on Invested Capital (ROIC)
- -3.48%
- Return on Capital Employed (ROCE)
- -0.04
- Revenue Per Employee
- 3.28M
- Profits Per Employee
- -1.31M
- Employee Count
- 577
- Asset Turnover
- 0.15
- Inventory Turnover
- 4.37
Valuation Ratios
The current PE Ratio of Microbio Co., Ltd. is 15.00. Microbio Co., Ltd.’s PEG ratio is 0.04.
- PE Ratio
- 15.00
- PS Ratio
- 4.03
- PB Ratio
- 0.75
- Price to FCF
- -32.27
- Price to Operating Cash Flow
- -36.43
- PEG Ratio
- 0.04
Income Statement
In the last 12 months, Microbio Co., Ltd. had revenue of 1.89B and earned -757.75M in profits. Earnings per share was -1.29.
- Revenue
- 1.89B
- Gross Profit
- 753.46M
- Operating Income
- -406.62M
- Pretax Income
- -951.58M
- Net Income
- -757.75M
- EBITDA
- -665.16M
- Earnings Per Share (EPS)
- -1.29
Cash Flow
In the last 12 months, operating cash flow was -196.01M and capital expenditures -49.15M, giving a free cash flow of -245.16M billion.
- Operating Cash Flow
- -196.01M
- Free Cash Flow
- -245.16M
- Free Cash Flow per Share
- -0.46
Dividends & Yields
Microbio Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.08%
- Earnings Yield
- 7.27%
Stock Price Statistics
- Beta
- 0.50
- 52-Week Price Change
- -36.52%
- 50-Day Moving Average
- 14.80
- 200-Day Moving Average
- 15.84
- Relative Strength Index (RSI)
- 27.29
- Average Volume (3m)
- 1.10M
Important Dates
Microbio Co., Ltd. upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- ―
Financial Position
Microbio Co., Ltd. as a current ratio of 4.30, with Debt / Equity ratio of 7.52%
- Current Ratio
- 4.30
- Quick Ratio
- 3.97
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.08
- Interest Coverage Ratio
- -34.68
Taxes
In the past 12 months, Microbio Co., Ltd. has paid 1.96M in taxes.
- Income Tax
- 1.96M
- Effective Tax Rate
- -0.00
Enterprise Valuation
Microbio Co., Ltd. EV to EBITDA ratio is -37.69, with an EV/FCF ratio of -32.95.
- EV to Sales
- 4.11
- EV to EBITDA
- -37.69
- EV to Free Cash Flow
- -32.95
- EV to Operating Cash Flow
- -41.21
Balance Sheet
Microbio Co., Ltd. has TWD 2.84B in cash and marketable securities with TWD 709.48M in debt, giving a net cash position of TWD 2.13B billion.
- Cash & Marketable Securities
- TWD 2.84B
- Total Debt
- TWD 709.48M
- Net Cash
- TWD 2.13B
- Net Cash Per Share
- TWD 3.62
- Tangible Book Value Per Share
- TWD 19.86
Margins
Gross margin is 36.39%, with operating margin of -23.77%, and net profit margin of 26.62%.
- Gross Margin
- 36.39%
- Operating Margin
- -23.77%
- Pretax Margin
- 13.40%
- Net Profit Margin
- 26.62%
- EBITDA Margin
- -10.91%
- EBIT Margin
- -25.06%
Analyst Forecast
The average price target for Microbio Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 8.41%
- EPS Growth Forecast
- ―
